# 2024-03-13--医药商业-九州通-医药流通领域民营龙头，创新战略落地有望迎来估值重塑_page27_图表43公司估值与同类公司相比具备性价比

|证券代码 |证券简称 |收盘价 |归母净利润增速（%） |PE |
|---|---|---|---|---|
|1099.HK |国药控股 |19.54 |9.89% |3.09%|
|601607.SH |上海医药 |18.35 |-5.92% |-11.10%|
|3320.HK |华润医药 |4.67 |19.45% |20.94%|
|310115.SZ |百洋医药 |33.98 |30.60% |29.05%|
|603883.SH |老百姓 |29.26 |17.29% |18.34%|
|平均值 | | |15.20% |13.41%|
|600998.SH |九州通 |8.04|-14.84% |17.59%|